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Genomics and Genetic Medicine: Pathways to Global Health? 
 
This special issue of Anthropology and Medicine contributes to emerging 
anthropological research examining the expanding terrain of genomic research and 
genetic medicine as a product of and vector for globalisation (Beaudevin and Pordie 
2016) and the ways it is being aligned with ‘Global Health’ (Koplan et al 2009).  It builds 
on a growing body of literature in anthropology that observes how this arena of science 
and medicine is unfolding across a range of national and transnational contexts with 
uneven and often inequitable consequences (Whitmarsh 2008, Fullwiley 2011, 
Sleeboom-Faulkner 2010, Wade et al 2014, Taussig and Gibbon 2014). The papers 
presented here explore comparatively and transnationally the complex and somewhat 
paradoxical interface between genomics and/or genetic medicine and the emerging 
landscape of ‘Global Health’. It is important to note that the meeting point between these 
domains is not new, with the WHO consistently highlighting the relevance of genetics to 
addressing human health since the 1950s. 1  Nevertheless, the recent expansion of 
genomics as a global and globalising research terrain marks a particular moment in the 
way that a domain of genetic knowledge and technology is being used to address a range 
of health care challenges. This now encompasses not only ‘rare’ disease but also the 
growing rates of non-communicable chronic disease in low- and middle-income 
countries, as well as infectious disease, with genetics becoming tied to large transnational 
epidemiological studies to address epidemics such as Malaria (see Achidi et al 2008).  
The way that genomics and genetic medicine are being configured as a pathway to 
‘Global Health’ in comparative national arenas beyond, but also often in close interaction 
with the ‘global north’, is of central importance for medical anthropology. 
 
The six papers included in this edition provide a multi-dimensional comparative 
perspective on how a focus on genomics and genetic medicine is being aligned with 
public health, discourses of prevention, questions of population difference, national 
sovereignty and processes of nationalisation. In doing so they are attentive to how 
structural inequities, issues of social (in)justice, and an emerging articulation of ‘rights’ 
to health services and resources shape these developments. While the specificity of 
national context is foregrounded in articles that examine how genomics and genetic 
medicine is unfolding in Brazil, Japan, China, United Arab Emirates (UAE), India and 
Qatar, we also see how these are related, often in disjunctured ways, to transnational 
parameters, as this concerns funding or research priorities or international ethical 
guidelines for research. While standardisation of the goals of genomic research or the 
                                                 
1 See Gaudillière, J.P. and Beaudevin, C,P. (2014-19) ‘Global health, From international public health to 
global health’  http://globhealth.vjf.cnrs.fr for further discussion of the history of and transformation of 
genomics in global health. 
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practices of genetic medicine is a component of these developments, it is not the only 
possibility or outcome (Gibbon et al. forthcoming 2018). The articles brought together 
here illustrate how a vast range of different research practices and techniques of health 
care intervention are increasingly encompassed under the aegis of genetics; an expansion 
that is happening at a time when the explanatory power of ‘the gene’ is being questioned 
but also reframed as an agentive component of gene-environment interactions in the 
emerging context of epigenetic research (Lock 2013). These practices now include 
research and medical interest in ‘rare’ or ‘intractable’ genetic diseases, population genetic 
screening and public health interventions aimed at ‘prevention’ as well as biobanking 
initiatives that may be argeted at specific populations. A number of the papers also attend 
to how medical genetics and genomics are unfolding and are being made relevant to 
chronic or common diseases, such as diabetes or cancer. In the social arenas outlined in 
the papers presented here, these are processes which are variously informed by particular 
cosmologies of the body and ill health, the uncertainties of rapid urban change, as well as 
socio-historic shifts in how legal ‘rights’ to health are being configured.  
In short, the papers in this collection examine the diverse expressions, dynamics 
and tensions in the way that different fields of genetic medicine and genomic research are 
being shaped by and helping to influence processes of globalisation. They provide a rich 
and engaging perspective contributing to emerging and ongoing anthropological 
examination of genomic research and medicine in underexamined regions within the 
‘global south’. In outlining the special issue in this introduction, we draw attention to 
three cross-cutting themes in how genetics and genomic medicine is being situated as a 
potential yet often still often elusive pathway in the pursuit of and at the interface with 
the shape shifting terrain of ‘Global Health’. This includes themes of inequalities and 
social justice, cosmology and population difference. 
 
Inequalities and social justice 
With calls to bridge the so-called ‘genomic health divide’ through economic 
investment in research and expanding the provision of genomic services and technologies 
to the ‘global south’, the issue of genomics and health inequalities has also become part 
of the landscape in which these developments are being shaped. ‘Genomics for the 
World’ was the headline of an article in Nature Genetics in 2011, where calls were made 
to widen the scope of genomics to include a greater diversity, to encompass ‘minority 
populations’ from ‘other ethnic groups’, and to ensure that ‘those most in need’ are ‘not 
the last to receive the benefits of genetic research’ (Bustamante et al 201:1651, see also 
Popejay and Fullerton 2016). The way a discourse of ‘humanitarianism’ is being 
foregrounded in relation to efforts to ensure those in the ‘global south’ are given the 
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‘right’ to become participants in and potential beneficiaries of genomic research demands 
critical and engaged attention (Fullwiley and Gibbon forthcoming 2018, Reardon 2012). 
Yet, in this moment of global expansion and ethical repositioning of genetic medicine 
and genomic technologies in terms of social inclusion and justice, the reality of 
inequitable and stratified access and rights to health care resources is also becoming 
apparent. Emerging research is demonstrating how different legal or policy 
infrastructures that make public health possible or delimit it in certain ways also shape 
how ‘rights’ to health care, increasingly including medications, treatment and screening 
interventions for genetic disease, are being pursued (Biehl 2013). In other cases, we see 
how these developments are informed by colonial and post-colonial histories, particularly 
in how populations are defined and made targets of genetic research and/or recipients of 
genetic medicine (Fullwiley 2011). But histories of eugenics and their ongoing 
contemporary manifestations, in terms of, for instance, embryo-selection practices in 
certain regions of the world, also have consequences for how the complex relationship 
between genomics and disabilities are unfolding. This is particularly so when a discourse 
of prevention is being fuelled by the expanding possibilities of prenatal screening. As 
Scully points out, the discourses and practices of ‘othering’ at stake in the expanding 
terrains of genomic research and medicine are often ‘subtle’ and ‘dispersed’ (forthcoming 
2018), demanding careful and nuanced social-science attention.  
Genetic Cosmologies 
The papers reveal a multiplicity of discourses, where both the global and the local 
participate in constituting the meaning, relevance and scope of genetics in different 
contexts; this means paying close attention to the way that different cosmologies are 
evoked, instrumentalised and transformed. Genomics and genetic medicine are often 
articulated to be novel and cutting-edge, but they also ironically point to tradition and 
inheritance. Profoundly meaningful, genetic understandings provide powerful idioms for 
the expression of individual and collective identity (Nash 2015; Nelson 2016). Whilst 
providing language for their expression, genetic discourses also contain potent 
possibilities for eliciting change in individual and social identity (Rabinow 1996). 
Increased genetic knowledge and the outcomes of its applications can impact the social 
fabric of society by impacting ideas of family (i.e. Panter-Brick 1991) and inheritance; 
they may become novel signifiers of identity, history and nationalism (Beaudevin 
2013:185). The nation appears in discussions around genomic patrimony and sovereignty 
(Rabinow 1999; Benjamin 2009): the economics of ‘biovalue’ (Waldby 2002) mean that 
DNA may be regarded as a national resource, as well as a repository of national 
characteristics. Genetic medicine and research can be harnessed as part of national 
aspirations and positionings as well as part of the state’s dedication to improving the lives 
of its citizens; but they also engage with global linkages beyond the nation.  
 
The contributors examine the expanding terrain of genomic research as a process, 
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which is characterized by both standardisation of knowledge and technologies and 
simultaneously locally configured. As genetic discourse develops in particular contexts, 
rather than replace cultural models, medical and scientific concepts are re-shaped and 
interpreted through local cosmologies, with tensions and negotiations often found at these 
junctures. As Shaw points out in her examination of British Pakistanis encountering 
genetic services in the UK, genetic explanations ‘provide a mechanism, but probabilistic 
concepts of chance leave a void that appeals to God’s will serve to fill’ (2009: 147). At 
the same time, and in various contexts genetic disorders are attributed to forces beyond 
human understanding, such as fate, destiny, and gods, as if in a kind of biological 
predestination (Featherstone et al. 2006: 113). Scientific notions of fate contained in 
genetic explanations and idioms intersect with traditional and religious conception of fate 
(i.e. Raz 2005) and when this occurs, both models are dynamically influenced, with novel 
meaning given to ideas of the body, inheritance, fate and kinship. Indeed, genetics has 
and continues to inform and complicate debates about what it means to ‘be in the world’ 
(Franklin, 1995). 
 
The fault lines between genetic populations 
New dilemmas have emerged around studies of the human genome and its 
parallels, the proteome and the epigenome, where the ultimate stated aim is to serve the 
development of global medicine as the provision of genetically specific medicine for 
certain populations. The ways in which genetic populations are defined, however, are 
closely linked to biopolitical issues, turning the definitions of genetic populations into 
fault lines among groups of people. Thus, battles are fought by patient groups to have 
their ‘genetic condition’ included into global or local research, whereby critique of race-, 
ancestor- and gender-based exclusion is rife (Epstein 2007; Fujimura and Rajagopalan 
2011; Gibbon 2016). In other contexts, however, worries about being included as a target 
for genetic medicine and experimentation are expressed, with fierce arguments being 
launched against the racialisation of population and in some cases the cleansing of 
particular populations of disabled peoples (Lewontin 2001; Duster 2006; Leach Scully 
2008; Kato 2010). And the science policies of some governments support genetic 
medicine to save healthcare spending by addressing the ‘problem’ of genetic conditions 
at their ‘root’. Such diverse approaches to genetic populations mark their controversial 
nature. 
 
Important to the development of genetic medicine is the study of the role 
of genetic factors in determining health and disease in families and in populations, or 
genetic epidemiology. Genetic epidemiologists usually refer to socio-political notions, 
such as gender, race and ethnicity and topographic terms in defining the analytical units 
of their research (M’Charek 2005; Fullwiley 2008). Such definitions are at once scientific 
and political when making societal processes, such as migration history and kinship 
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systems, genetically relevant to their research, even before the research has even taken 
place (Lewontin 2001). A main aim of genetic epidemiology is to understand the relation 
between a population’s genetic make-up and the environment. In the case of a genetic 
predisposition for Diabetes or Sickle Cell Disease, for instance, this can enable the state 
to implement policies with the aim of changing people’s every-day or mating behaviour 
through educational and screening measures (Patra & Sleeboom-Faulkner 2010; 
Sleeboom-Faulkner 2011). In short, no approach to genetic medicine is politically 
straightforward; they are intimately linked to issues of social justice and equality 
(Sleeboom-Faulkner 2007; Fullwiley & Gibbon forthcoming 2018), cultural politics 
(Sleeboom-Faulkner 2006; Gibbon & Novas 2007; Kato & Sleeboom-Faulkner 2009; 
Kuo 2011; Kilshaw at al 2015), imagined genetic communities (Simpson 2000; Wade et 




As the synopses below illustrate, the papers in this volume illuminate how genomics and 
genetic medicine is an arena which is shaped and itself is transformed by relations of 
inequality and social justice, by differing cosmologies and by how populations are 
defined and redefined by actors involved and implicated in these terrains of research and 
health care. 
 
Sahra Gibbon and Waleska Aureliano in their Inclusion and Exclusion in the 
Globalisation of Genomics; the case of rare genetic disease in Brazil show how rare 
disease in the globalisation of genomic medicine is locally constituted and remade. This 
paper nuances debates on the politics of difference that link the coining of rare diseases 
with particular patient rights to healthcare facilities and investment in the life sciences 
(e.g., Epstein 2007). It does so by showing how in a context of severely constrained 
healthcare resources, and where the specificity of genetic diseases whose aetiologies and 
population frequencies are often contested or unknown, rareness can become a means to 
promote social justice and health care rights. While in the US, race and gender appear to 
more explicitly shape the inclusion of populations in medical research, in Brazil this 
process is also informed by ‘judicialisation’: ‘a politics predicated on efforts by patients, 
families and patient support organisations to oblige the state to meet a constitutional 
commitment to provide health care to all’. Outlining how interest in rare genetic disease 
has emerged in dialogue with paediatrics and oncology and in relation to a partial and 
inequitably distributed system of public health, the authors illustrate the complex 
feedback loops between clinical care and research, patient mobilisation and recent state 
legislation. The genetic conditions of interest in their paper, centred on cancer genetic 
syndromes and a form of hereditary ataxia, reveal how the ‘rarenesss’ of disease has been 
diversely situated and differently politicized. Illustrating how clinicians, patients and their 
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families grapple with the boundaries between research and the right to health as well as 
the necessity and limits of care, therapy and prevention, the authors show how the 
dynamics of inclusion and exclusion play out differently, even paradoxically across and 
within these different arenas of genetic medicine.  
 
Sangeeta Chatto in Inherited blood disorders, genetic risk and global public 
health: framing ‘birth defects’ as preventable in India explores what she describes as an 
‘ethical moment’ in the WHO re-classification of Inherited Blood Disorders or IBD’s 
(such as Sickle Cell Disease and Thalassemia) as ‘preventable’. This intervention is she 
argues part of a ‘globalising turn’ in the way that IBD’s are being framed as a ‘global 
health crisis’ and in the way that genomics is being used to address structural inequalities 
that inform and shape health outcomes in low and middle-income countries (LMICs). 
Taking India as one social arena for these developments (see Beaudevin 2013 for an 
examination of these developments in Oman) she illustrates how specific colonial 
histories of racial classification, as this relates to caste and tribe, shape how a globalising 
discourse of risk relating to IBD’s is mapped to certain populations and makes them 
‘bioavailable’. Given histories of intervention by the Indian state to control the 
reproductive capacity of certain ethnically marginalized communities through coercive 
use of abortion and sterilisation, and ongoing evidence of sex selective terminations of 
female fetuses, the implications of framing and intervening on IBD’s in this way are 
profound. The challenge for public health in LMICs, as much as elsewhere is, as she 
points out, to engage with biological difference, disease variability and molecular 
heterogeneity while being attentive to the ever-present possibilities of essentialising and 
de-politicising health inequalities. In a context where there are dense intersections 
between gender, race, genetics, stratified reproduction and disability we need, she argues, 
to urgently attend to the ‘erasures’ at stake in situating IBD’s as preventable. 
 
Susie Kilshaw’s article Qatari Intersections with Global Genetics Research and 
Discourse illustrates how a focus on genetic discourses is part of national and 
nationalising aspirations for modernity in Qatar. Genetic medicine and research is at the 
forefront of the state’s mission to be a world leader in research, education and 
international politics and provide cutting-edge approaches to health care for the country. 
At the same time this nevertheless rests on a definition of the ‘nation’ that excludes 
significant section of the population, such as Qatar’s immigrant underclass of 
construction workers. These ‘national’ aspirations also co-exist and sit in tension with a 
traditional emphasis on inheritance and are often in contention with the way that local 
Qatari's themselves understand and incorporate genetic knowledge into their lives. In this 
sense she, like Aaron Parkhurst (this edition), demonstrates how different cosmologies, 
that aspire to the modern and which reinvigorate traditional values, are characterised by a 
constant movement and process of re-invention as the country and its people negotiate 
 7 
the new possibilities afforded by genomic knowledge and technologies. In exploring the 
way local Qatari systems of knowledge intersect with modernising genetic discourses the 
paper highlights the unevenness of change. Kilshaw outlines how ‘close’ family marriage 
and the traditional practice of marrying cousins, provide a particular lens for examining 
how cosmopolitan and traditional values and practices are aligned or negotiated and 
become strategies for ‘containtment’ in relation to discourse of genetic risk. As others 
have explored elsewhere (see for instance Shaw 2015) she demonstrates how discourses 
and practices of consanguinity are at the heart of these intersections, illuminating how 
issues of modernity and tradition are being negotiated and/or contested in a variety of 
global contexts.  In the Qatari contexts that Kilshaw investigates there are a multiplicity 
of discourses where both the global and the local participate in constituting the meaning 
of genetics and where ‘global frictions’ (Tsing 2005) are just one possibility. 
 
Aaron Parkhurst in his City and Cosmology:  Genetics, Health, and Urban living 
in Dubai discusses the role of modernity and global flows in perceptions of the health of 
society through his ethnography in the UAE. In this context, there is an increased 
susceptibility of nationals to some diseases, such as diabetes, and agentic discourses have 
predominated in approaches to combating these conditions. However, despite widespread 
dissemination of genomic knowledge and its general public acceptance, the rates of 
diabetes, obesity and heart disease continue to increase. Parkhurst sets out to shed light 
on this seeming contradiction by exploring the clash between indigenous and imported 
biomedical knowledge systems and does so with specific reference to the city and rapid 
urban growth. He argues that chronic illness in the Emirates is partly the result of the 
ways in which many local people define what modernity means to them. Some 
conditions, like diabetes, are understood to have been brought by the West and represent 
ambivalence around modernity and outside influences. Such conditions, however, are 
also understood to result from a loss of valued traditional values. In the UAE, genes have 
been incorporated into indigenous cosmology: the language and rhetoric that his 
participants apply to discourses of fate are re-appropriated to help them think through 
genetics and other biomedical body knowledge. Instead of usurping them, a public health 
emphasis on the ‘Arab Genome’ has instead reinforced cosmological understandings of 
disease.  Parkhurst suggests new local understandings of genetics give novel meanings to 
inheritance and share an intimate relationship with traditional ideas of fate and national 
identity. In the context of rapid urban growth, structures of cosmology are relied upon to 
cope with radical uncertainty and are applied to the body and to emergent biomedical 
categories. He argues that health care policy and planning should be informed by local 
cosmology and particularly be cognizant of how people ‘pivots itself against a world’ that 




Masae Kato’s paper Genomics and Cure: Understanding narratives of patients 
with Duchenne Muscular Dystrophy in Japan questions the presumption that all patients 
with a serious intractable disease are looking to genetic medicine for a cure for their 
condition. Having conducted in-depth interviews with patients with Duchenne Muscular 
Dystrophy (DMD), Kato observed how DMD patients perceive medical and scientific 
attempts at creating genetic medicine. She carefully outlines how attitudes towards 
genetics in Japan, are not only closely related to the backlash against the history of 
eugenics in that country (Matsubara 2003; Kato & Sleeboom-Faulkner 2017), but also to 
the lives and identities that individuals with DMD have built. In other words, the idea of 
finding a cure may not always be attractive to individuals with a condition, if this means 
that their life, identity and values may alter radically as a result of genetic therapy. 
Furthermore, whether individuals desire a genetic cure also depend on the socio-cultural 
conditions, such as acceptance by society, employment conditions, availability of medical 
and care, and the healthcare provided in a country. In brief, this case-study of DMD 
patients in Japan shows that patients, depending on their local circumstances and needs, 
will value genomic medicine differently. It serves as a warning against a widespread bias 
that the development of genetic medicine, rather than other medicine or facilities, are in 
the interest of patients with serious, intractable diseases.  
 
Margaret Sleeboom-Faulkner’s timely contribution The justification of studies in 
genetic epidemiology – political scaling in China Medical City, drawing on research 
conducted in Taizhou, China, argues that the way science is organized and financed leads 
to the strategic practice of ‘political scaling’ among scientists, who zoom in on particular 
relations between communities and research. Effectively, an intervention itself, the 
paper’s aim is not to understand genetic epidemiology as a cultural system but rather to 
influence/critique its practice and conceptual assumptions. Her discussion provides a lens 
to understand issues and scientific practices about biobanking in China and knowledge-
making in epidemiology in general. Political scaling in genetic epidemiology research 
means that research is justified by speculation on the relevance of data on a relatively 
small sample population to much wider populations, or overgeneralisation. Constituting a 
mismatch of scales in relevance, reach and research ethics of a study means losing sight 
of how the study links sample donating and benefiting communities. In the case of the 
Taizhou Longitudinal database, the GE study is largely supported by state institutions and 
justified in terms of state policies. However, it is also dependent on international 
scientific discourses through which it gains international recognition. The implications 
for the study design of this are that populations need to be defined and generalized that 
conform to aims of both investors and scientific audiences at home and abroad. 
Sleeboom-Faulkner clearly shows how anthropological fieldwork can play a 
complementary role to genetic epidemiology by examining the particular discourses of 
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